Stock KROS KEROS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Keros Therapeutics, Inc.

Equities

KROS

US4923271013

Market Closed - Nasdaq
Other stock markets
 03:59:47 2024-06-04 pm EDT 		5-day change 1st Jan Change
49.49 USD +1.68% Intraday chart for Keros Therapeutics, Inc. +1.52% +24.47%
May. 28 Keros Therapeutics, Inc. Appoints Jean-Jacques Bienaimé to Its Board of Directors and to Serve as A Member of the Nominating Committee, Effective June 1, 2024 CI
May. 08 Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
KEROS THERAPEUTICS, INC. Stock Keros Therapeutics, Inc.
 1.76B -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 24.82B -
ARGENX SE Stock argenx SE
 22.48B -
GENMAB A/S Stock Genmab A/S
 18.32B
  1. Stock Market
  2. Equities
  3. KROS Stock
  4. Charts Keros Therapeutics, Inc.
  5. Sector Chart